US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist
  • 495.260
  • +3.000+0.61%
Close Jul 26 16:00 ET
  • 496.000
  • +0.740+0.15%
Post 16:39 ET
127.80BMarket Cap32.14P/E (TTM)

Vertex Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vertex Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 1, 2024

Revenue(YoY)

2.66B

+6.89%
EPS(YoY)

-13.15

-473.54%
Analyst Rating

Buy

Jul 26, 2024

Vertex Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 22 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.689B--
Aug 1, 20242024/Q2-- / 2.665B--
--2024/Q12.691B / 2.580B--
Feb 5, 20242023/Q42.518B / 2.515B--
Nov 6, 20232023/Q32.484B / 2.502B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.689B--
Aug 1, 20242024/Q2-- / 2.665B--
--2024/Q12.691B / 2.580B--
Feb 5, 20242023/Q42.518B / 2.515B--
Nov 6, 20232023/Q32.484B / 2.502B--

Unlock Free Earnings Estimates

Vertex Pharmaceuticals Earnings Reports

  • Vertex Pharmaceuticals | 10-Q: Quarterly report

    May 7 16:50 ET

  • Vertex Pharmaceuticals | 10-K: Annual report

    Feb 15 16:20 ET

  • Vertex Pharmaceuticals: Q3 2023 Earnings Report

    Nov 7, 2023 16:16 ET

  • Vertex Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 2, 2023 16:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 26, 2024

    Buy

    • Buy

      69.57%

    • Hold

      21.74%

    • Sell

      8.70%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept Gene Editing
    Gene Editing
    Intraday+0.95%